Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
Resource Type
Article
Authors
Blay, Jean-Yves ; Chevret, Sylvie ; Le Cesne, Axel ; Brahmi, Mehdi ; Penel, Nicolas ; Cousin, Sophie ; Bertucci, Francois ; Bompas, Emmanuelle ; Ryckewaert, Thomas ; Soibinet, Pauline ; Boudou-Rouquette, Pascaline ; Saada Bouzid, Esma ; Soulie, Patrick ; Valentin, Thibaud ; Lotz, Jean-Pierre ; Tosi, Diego ; Neviere, Zoé ; Cancel, Mathilde ; Ray-Coquard, Isabelle ; Gambotti, Laetitia ; Legrand, Frédéric ; Lamrani-Ghaouti, Assia ; Simon, Clotilde ; Even, Caroline ; Massard, Christophe
Source
In The Lancet Oncology August 2023 24(8):892-902
Subject
Primary Research Articles
Language
ISSN
1470-2045